Globus Medical Receives FDA 510(k) Clearance For ExcelsiusFlex And ACTIFY 3D Total Knee System
Portfolio Pulse from Benzinga Newsdesk
Globus Medical, Inc. (NYSE:GMED) has received FDA 510(k) clearance for its ExcelsiusFlex robotic navigation platform and ACTIFY 3D Total Knee System, enhancing its offerings in Total Knee Arthroplasty.
July 17, 2024 | 12:36 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Globus Medical has received FDA 510(k) clearance for its ExcelsiusFlex robotic navigation platform and ACTIFY 3D Total Knee System, which could enhance its market position in Total Knee Arthroplasty solutions.
The FDA 510(k) clearance for ExcelsiusFlex and ACTIFY 3D Total Knee System is a significant regulatory milestone for Globus Medical. This approval allows the company to market these advanced products, which could lead to increased adoption by surgeons and healthcare facilities. The enhanced capabilities in Total Knee Arthroplasty could strengthen GMED's competitive position and drive revenue growth.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100